Relay Therapeutics (RLAY) PT Raised to $15 at Wells Fargo
Tweet
Share
E-mailGet Alerts RLAY Hot Sheet
Price: $20.05 -0.1%
Rating Summary:
16 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 14 | New: 9
Rating Summary:
16 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 14 | New: 9
Join SI Premium – FREE
Wells Fargo analyst Eva Fortea Verdejo raised the price target on Relay Therapeutics (NASDAQ: RLAY) to $15.00 (from $13.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Riskified Ltd. (RSKD) PT Raised to $7.50 at DA Davidson on Improving New Business Trends
- OptimizeRX (OPRX) PT Lowered to $12 at Stifel, Buy Rating Maintained
- Brinker Int'l (EAT) PT Raised to $285 at UBS Following 'Impressive' Q4 Outperformance
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
